Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats

Ping Mu, Long Chuan Yu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The present study was performed to investigate the effects of valproic acid sodium (VPA), a widely utilized antiepileptic drug, on the establishment of chronic morphine-induced conditioned place preference (CPP). The rat model of morphine-induced CPP was conditioned with alternating intracerebroventricular (i.c.v.) injections of morphine (60 μg/6 μl) and saline for 5 days. To investigate the influence of VPA on morphine-induced CPP, rats received chronic pretreatment of i.c.v. VPA (500 μg/rat) 10 min previous to the daily morphine injection. The results demonstrated that the morphine-induced CPP was significantly attenuated by VPA pretreatment, while the VPA itself could not induce any CPP or conditioned place aversion (CPA) effects. The results of the present study not only confirmed the reliability of establishing morphine-induced CPP model by i.c.v. injection, but also suggest that the antiepileptic drug VPA may be utilized as potential therapeutic medications for drug abuse in the future.

Original languageEnglish (US)
Pages (from-to)135-138
Number of pages4
JournalNeuroscience Letters
Volume426
Issue number3
DOIs
StatePublished - Oct 22 2007
Externally publishedYes

Fingerprint

Valproic Acid
Morphine
Central Nervous System
Sodium
Anticonvulsants
Injections
Substance-Related Disorders

Keywords

  • Conditioned place preference (CPP)
  • Drug abuse
  • Intracerebroventricular (i.c.v.)
  • Morphine
  • Valproic acid sodium (valproate, VPA)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. / Mu, Ping; Yu, Long Chuan.

In: Neuroscience Letters, Vol. 426, No. 3, 22.10.2007, p. 135-138.

Research output: Contribution to journalArticle

@article{790d3dd3d2bb44f6a97c826fcab1629a,
title = "Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats",
abstract = "The present study was performed to investigate the effects of valproic acid sodium (VPA), a widely utilized antiepileptic drug, on the establishment of chronic morphine-induced conditioned place preference (CPP). The rat model of morphine-induced CPP was conditioned with alternating intracerebroventricular (i.c.v.) injections of morphine (60 μg/6 μl) and saline for 5 days. To investigate the influence of VPA on morphine-induced CPP, rats received chronic pretreatment of i.c.v. VPA (500 μg/rat) 10 min previous to the daily morphine injection. The results demonstrated that the morphine-induced CPP was significantly attenuated by VPA pretreatment, while the VPA itself could not induce any CPP or conditioned place aversion (CPA) effects. The results of the present study not only confirmed the reliability of establishing morphine-induced CPP model by i.c.v. injection, but also suggest that the antiepileptic drug VPA may be utilized as potential therapeutic medications for drug abuse in the future.",
keywords = "Conditioned place preference (CPP), Drug abuse, Intracerebroventricular (i.c.v.), Morphine, Valproic acid sodium (valproate, VPA)",
author = "Ping Mu and Yu, {Long Chuan}",
year = "2007",
month = "10",
day = "22",
doi = "10.1016/j.neulet.2007.04.017",
language = "English (US)",
volume = "426",
pages = "135--138",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats

AU - Mu, Ping

AU - Yu, Long Chuan

PY - 2007/10/22

Y1 - 2007/10/22

N2 - The present study was performed to investigate the effects of valproic acid sodium (VPA), a widely utilized antiepileptic drug, on the establishment of chronic morphine-induced conditioned place preference (CPP). The rat model of morphine-induced CPP was conditioned with alternating intracerebroventricular (i.c.v.) injections of morphine (60 μg/6 μl) and saline for 5 days. To investigate the influence of VPA on morphine-induced CPP, rats received chronic pretreatment of i.c.v. VPA (500 μg/rat) 10 min previous to the daily morphine injection. The results demonstrated that the morphine-induced CPP was significantly attenuated by VPA pretreatment, while the VPA itself could not induce any CPP or conditioned place aversion (CPA) effects. The results of the present study not only confirmed the reliability of establishing morphine-induced CPP model by i.c.v. injection, but also suggest that the antiepileptic drug VPA may be utilized as potential therapeutic medications for drug abuse in the future.

AB - The present study was performed to investigate the effects of valproic acid sodium (VPA), a widely utilized antiepileptic drug, on the establishment of chronic morphine-induced conditioned place preference (CPP). The rat model of morphine-induced CPP was conditioned with alternating intracerebroventricular (i.c.v.) injections of morphine (60 μg/6 μl) and saline for 5 days. To investigate the influence of VPA on morphine-induced CPP, rats received chronic pretreatment of i.c.v. VPA (500 μg/rat) 10 min previous to the daily morphine injection. The results demonstrated that the morphine-induced CPP was significantly attenuated by VPA pretreatment, while the VPA itself could not induce any CPP or conditioned place aversion (CPA) effects. The results of the present study not only confirmed the reliability of establishing morphine-induced CPP model by i.c.v. injection, but also suggest that the antiepileptic drug VPA may be utilized as potential therapeutic medications for drug abuse in the future.

KW - Conditioned place preference (CPP)

KW - Drug abuse

KW - Intracerebroventricular (i.c.v.)

KW - Morphine

KW - Valproic acid sodium (valproate, VPA)

UR - http://www.scopus.com/inward/record.url?scp=34848883583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848883583&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.04.017

DO - 10.1016/j.neulet.2007.04.017

M3 - Article

C2 - 17904288

AN - SCOPUS:34848883583

VL - 426

SP - 135

EP - 138

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -